Search results
Salesforce shareholders reject compensation plan for CEO, other top executives - ET Telecom
The Economic Times· 6 days agoThe resolution to approve the compensation received 339.3 million votes in favor versus 404.8...
Saks Fifth Avenue Owner to Buy Neiman Marcus for $2.65 Billion—With Aid from Amazon
Sourcing Journal· 5 days agoIn a digital age twist, Amazon is an investor in the deal, as are private equity giant Apollo and ...
TD Cowen: Saks-Neiman Deal Likely a Boon to Both Retailers Amid Brand Moves to DTC
Sourcing Journal· 3 days agoBaker, who had been vying for a merger between subsidiary Saks and Neiman for about a decade, is...
Sundar Pichai, Satya Nadella, Mark Zuckerberg and other tech CEOs on why companies are making job...
The Times of India· 10 hours agoThe tech industry's layoffs haven't stopped. After starting in 2023, many companies like Google, Microsoft, Facebook parent Meta and Amazon, among others, are still cutting jobs in 2024. Recently ...
FMCG majors ramp up direct reach in distribution push
Financial Express· 16 hours agoAt over a third of total reach currently, from around 20% earlier
OpenAI to join Washington lobbying group BSA | The Software Alliance
Semafor· 5 days agoThe group is expected to announce on Wednesday that OpenAI will become a global member, adding to a...
Unacademy gives pink slips to 250 employees in another round of layoffs
Business Standard India· 6 days agoEdtech firm Unacademy has laid off 250 people across verticals, according to people familiar with...
Federal Bank plans co-branded credit cards with non-fintech partners after RBI curbs
CNBC Awaaz· 4 days agoPrivate sector lender Federal Bank plans to onboard non-fintech partners for co-branded credit...
Karisma Hotels partners with Dobrov to develop hotel in Montenegro
Hotel Management Network· 3 days agoLast year, Karisma Hotels & Resorts signed an agreement withSalesforce and TELMEX, a Mexico-based...
5 FDA decisions to watch in the third quarter
BioPharma Dive· 5 days agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...